The Methodist Neurological Institute’s Eddy Scurlock Stroke Center, the largest stroke unit in Houston’s Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.
Research shows that managing and treating vascular disease risk factors are not only beneficial to preventing heart disease and stroke, but also common forms of dementia.
A 66-year-old Houston woman’s golf ball-sized breast tumor is now almost invisible to the naked eye after only four rounds of an investigational drug regimen.
Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an investigational drug believed to hamper cancer cells.
Dr. Kenneth Podell, a neuropsychologist focused on concussion and head injuries, joins the Methodist Concussion Center in Houston as co-director. Podell will also be the team neuropsychologist consultant for the Houston Texans, Houston Astros, Houston Dynamo and Rice Athletics.
College freshmen often joke about gaining the “Freshman 15,” even though research shows most new college students only gain 3.5 pounds their first year of college. But even that modest weight gain should be taken seriously—transitioning from high school to college should not lead to unwanted pounds and expanded waistlines.
The Methodist Hospital ranked among the country’s top hospitals in 13 specialties in U.S. News & World Report’s 2012 America’s “Best Hospitals”issue, and was named the No. 1 hospital in Texas.
Heart transplant patient, Brian Gilliam, fought for his life now he will lead 31 transplant patients to the Transplant Games of America in Grand Rapids, MI.
Grants from the U.S. Department of Health & Human Services totaling $26.2 million will support work by The Methodist Hospital in Houston to reduce blood infections and delirium-caused injuries in Texas hospitals. The three-year grants are covered by the Patient Protection and Affordable Care Act of 2010.
Doctors are looking at more than age when it comes to giving someone a new kidney.
A pair of new papers by scientists at The Methodist Hospital Research Institute (TMHRI) and six other institutions suggests these microscopic workhorses ought to be disc-shaped, not spherical or rod-shaped, when targeting cancers at or near blood vessels.
Bryan M. Spann, D.O., Ph.D., adds clinical leadership to Methodist’s Alzheimer’s program.
If a patient with a pacemaker needs an MRI for the brain or orthopedic injury, doctors at the Methodist DeBakey Heart & Vascular Center in Houston can now reprogram the device so they can now receive one.
Nanomedicine researchers at the Methodist Neurological Institute and Rice University have developed a way to selectively kill brain cancer cells by using a tiny syringe to deliver a combination of chemotherapy drugs directly into the cells. These findings will be published in the April 24 issue of the American Chemical Society journal ACS Nano.
Heart cells starved of nutrients are less likely to be damaged during periods of decreased blood flow and sudden influxes of blood, known as ischemia and reperfusion, and are also less likely to get out of synch with their cellular neighbors, the damaging phenomenon called arrhythmia.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc.
When Methodist DeBakey Heart & Vascular Center cardiologist William Zoghbi, M.D., takes over the helm of the world's largest society of cardiologists March 26, he says he will begin creating and expanding programs that directly help patients.
A global team led by scientists from The Methodist Hospital Research Institute has identified more than 500 genes that may cause or contribute to the development of pancreatic cancer. This particularly deadly disease has a 1-in-20 survival rate after five years, largely because no effective genetic screening method exists for early detection.
New technology that measures the facial parameters of stress through heat generation is being used to train surgeons on whether or not they are competent enough to perform laproscopic surgery.
Physicians at the Methodist Neurological Institute are studying the use of human stem cells as a possible treatment for acute ischemic stroke, a leading cause of death and disability. Each year, stroke affects more than 15 million people around the world.
The return of daylight saving time and losing an hour of sleep causes most to cringe at the thought. According to Aparajitha Verma, M.D., medical director of the Sleep Disorders Center at the Methodist Neurological Institute in Houston, “springing forward” affects the sleep patterns of more than 70 million Americans.
Interventional cardiologists have, for the first time, repaired a large coronary artery aneurysm with stent-assisted coil embolization without doing open heart surgery. The successful procedure could mean a new option for patients, especially those who would be at risk undergoing an open chest operation. The work is published in the February issue of Circulation: Cardiovascular Interventions, an American Heart Association journal.
According to the Centers for Disease Control, sports-related concussions are an epidemic in this country. With more than three million sports-related concussions happening every year, research shows the effects can be long-lasting, even leading to permanent brain damage and early onset of dementia. Dr. Howard Derman, director of the Methodist Concussion Center in Houston, shares some of the common misconceptions about the brain and the severity of head injuries.
Erectile dysfunction is a precursor to more serious health problems such as heart disease. Getting problems like diabetes under control are more important than your performance in the bedroom.
A new device help people with foot drop walk.
By shining infrared light on specially designed, gold-filled silicon wafers, scientists at The Methodist Hospital Research Institute have successfully targeted and burned breast cancer cells. If the technology is shown to work in human clinical trials, it could provide patients a non-invasive alternative to surgical ablation, and could be used in conjunction with traditional cancer treatments, such as chemotherapy, to make those treatments more effective.
The Methodist Hospital in Houston is one of three academic medical centers in the country to win a top patient satisfaction award from Press Ganey, a national consulting firm focused on improving health care performance.
An anti-malaria drug used for more than 60 years is now being studied for use in breast cancer patients whose disease has not responded to traditional chemotherapy treatment.
The rise in fatty liver and obesity might cause more transplants in the future. The problems is there might not be enough organs, forcing doctors to leave certain patients off the list.
Getting back on a diet plan immediately after big holiday meals will help cut down on the holiday weight gain.
Many people are rediscovering the ancient practice of nasal irrigation to flush out the gunk that can build up in nasal passages and can cause irritation or infection. Dr. Donald Donovan, an otolaryngologist at The Methodist Hospital in Houston, says if done correctly the practice is safe and beneficial.
Below are tips from The Methodist Hospital in Houston on how to enjoy the holiday season by managing stress, avoiding excessive caffeine and eating a healthier diet. To follow up on any of these helpful tips, contact information can be found below.
Doctor describes simple way you can protect you and your family against colds and flu.
The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.
World Alzheimer’s Day is Sept. 21, 2011. Dr. Gustavo C. Roman, director of the Nantz National Alzheimer Center at the Methodist Neurological Institute, addresses some common misconceptions about this devastating disease.
Cardiologist William Zoghbi, M.D., will address the United Nations Summit on Non-Communicable Diseases next week (Sept. 19 and 20) to argue that abating heart disease should be a target of the United Nations' eight Millennium Development Goals. Zoghbi is president-elect of the American College of Cardiology.
We put the kids first all summer and eat more when we are with them and on vacation. Now is the time to buckle down and take care of yourself.
People who received intensive medical treatment following a first stroke had fewer second episodes and were less likely to die than people who received brain stents in addition to medical treatment, according to a new report in the New England Journal of Medicine, to be published online Sept. 7. All patients in the study had experienced one stroke and were considered at high risk for a second one.
Dr. Brian Miles, a urologist with The Methodist Hospital, answer questions about prostate cancer and tries to help patients determine fact from fiction. September is Prostate Cancer Awareness Month
Breast cancer awareness has increased over the past decade with walks for the cure, celebrities speaking out about their experiences and proceeds of pink-ribboned products going to breast cancer research. Even with a greater level of awareness, rumors and myths about breast cancer continue to circulate. Dr. Angel Rodriguez, director of the Triple Negative Breast Cancer Clinic at the Methodist Cancer Center in Houston, clears up some common misconceptions about breast cancer.
A patient who had symptoms of inhalation anthrax infection and who eventually succumbed to the disease was actually infected by a different bacterial species that had acquired anthrax toxin genes.
The Methodist Hospital Research Institute and Philips Healthcare are collaborating to develop new imaging technology that could be used to help identify the start -- and cause -- of an infectious disease epidemic.
Three tips from The Methodist Hospital on how recent financial turmoil may also be causing physiological turmoil.
Although disappointed by the retirement of the Space Shuttle program, a former astronaut and a biochemist who has flown experiments aboard the last two U.S. space shuttle missions both believe the outlook on research in a near-zero gravity environment should remain optimistic.
Dr. Robert G. Grossman, chairman of neurosurgery and co- director of the Methodist Neurological Institute, will receive the Rick Hansen Difference Maker award for his outstanding contributions in the field of spinal cord injury research.
An internationally-acclaimed husband and wife team that has identified hundreds of genes that cause cancer joins The Methodist Hospital Research Institute (TMHRI) in Houston as the first luminary scholars recruited by Texas through the Cancer Prevention and Research Institute of Texas (CPRIT). They begin October 3.
Two new drugs, recently approved by the FDA, have significantly improved the cure rates of people with hepatitis C. One drug, Victrelis, showed a dramatic improvement in African Americans.
Women trying to fit in beautiful shoes that are too tight can cause a whole host of foot problems.
A 59-year-old Houston man became the first individual in the United States to enroll in a study using stem cell transplantation during cardiac bypass to treat severe heart failure.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right